Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT05198934 2026-04-27

CodeBreak300

Phase 3 Completed

160 enrolled 1 FDA

Gastrointestinal

Colorectal Neoplasms

NCT04776148 2026-02-05

MK-7902-017

Phase 3 Completed

563 enrolled 32 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT05600309 2025-11-26

A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study

Phase 3 Completed

94 enrolled 15 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT03829462 2025-11-21

NEXT-REGIRI

Phase 3 Active not recruiting

377 enrolled 30 charts

Gastrointestinal

Colorectal Neoplasms

NCT05425940 2025-10-23

STELLAR-303

Phase 3 Active not recruiting

901 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07134205 2025-08-21

The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer

Phase 3 Not yet recruiting

252 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05328908 2025-08-13

RELATIVITY-123

Phase 3 Terminated

770 enrolled

Gastrointestinal

Spinocerebellar Degenerations, Colorectal Neoplasms

NCT06992648 2025-05-28

REGTAS-2

Phase 3 Recruiting

302 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02934529 2025-04-16

AIO-KRK-0114

Phase 3 Completed

673 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02788279 2019-12-11

A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)

Phase 3 Completed

363 enrolled 19 charts

Gastrointestinal

Colorectal Neoplasms

NCT01853319 2019-04-22

REGARD

Phase 3 Completed

100 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT01939223 2017-10-20

COAST

Phase 3 Terminated

25 enrolled 6 charts

Gastrointestinal

Colorectal Neoplasms

NCT01584830 2016-02-08

CONCUR

Phase 3 Completed

204 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01103323 2015-06-24

Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy

Phase 3 Completed

760 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

NCT01786538 2013-03-13

Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines

Phase 3 Withdrawn

Gastrointestinal

Colorectal Neoplasms